Consensus treatments for moderate juvenile dermatomyositis: Beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference

Arthritis Care and Research

Volumn 64, Issue 4, 2012, Pages 546-553

  Huber, Adam M ^a   Robinson, Angela B ^b   Reed, Ann M ^c   Abramson, Leslie ^d   Bout Tabaku, Sharon ^e   Carrasco, Ruy ^f   Curran, Megan ^g   Feldman, Brian M ^h   Gewanter, Harry ⁱ   Griffin, Thomas ^j   Haines, Kathleen ^k   Hoeltzel, Mark F ^l   Isgro, Josephine ^m   Kahn, Philip ⁿ   Lang, Bianca ^a   Lawler, Patti ^o   Shaham, Bracha ^p   Schmeling, Heinrike ^q   Scuccimarri, Rosie ^r   Shishov, Michael ^s   Stringer, Elizabeth ^a   Wohrley, Julie ^o   Ilowite, Norman T ^t   Wallace, Carol ^u   more..

^a DALHOUSIE UNIVERSITY   (Canada)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e NATIONWIDE CHILDREN S HOSPITAL   (United States)

^f DELL INC   (United States)

^g CHILDREN'S MEMORIAL HOSPITAL   (United States)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

ⁱ Pediatric and Adolescent Health Partners   (United States)

^j CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^k HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^l CHILDREN S MERCY HOSPITAL   (United States)

^m NEW YORK PRESBYTERIAN HOSPITAL   (United States)

ⁿ NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o Cure JM Foundation   (United States)

^p UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^q UNIVERSITY OF CALGARY   (Canada)

^r MONTREAL CHILDREN S HOSPITAL   (Canada)

^s PHOENIX CHILDREN'S HOSPITAL   (United States)

^t ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^u UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ARTICLE; CHILDHOOD DISEASE; COMBINATION CHEMOTHERAPY; CONSENSUS DEVELOPMENT; DERMATOMYOSITIS; DISEASE EXACERBATION; DRUG DOSE REDUCTION; MEDICAL SOCIETY; MEDICAL SPECIALIST; STEROID THERAPY; TREATMENT PLANNING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; STEROIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84859764386     PISSN: 00043591     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.20695     Document Type: Article

References (14)

1. Bitnum S, Daeschner C Jr, Travis LB, Dodge WF, Hopps HC. Dermatomyositis. J Pediatr 1964;64:101-31.
2. Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria R, Malleson P, et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000;43:541-9. (Pubitemid 30394944)
3. Stringer E, Ota S, Bohnsack J, Bowyer SL, Griffin TA, Huber AM, et al. Treatment approaches to juvenile dermatomyositis across North America: the Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM treatment survey. J Rheumatol 2009;37:1953-61.
4. Huber AM, Giannini EH, Bowyer SL, Kim S, Lang B, Lindsley CB, et al. Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference. Arthritis Care Res (Hoboken) 2010;62:219-25.
5. Ebell MH, Siwek J, Weiss BD, Woolf SH, Susman J, Ewigman B, et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician 2004;69:548-56. (Pubitemid 38176273)
6. Sox HC. Defining comparative effectiveness research: the importance of getting it right. Med Care 2010;48 Suppl:S7-8.
7. Tunis SR, Benner J, McClellan M. Comparative effectiveness research: policy context, methods development and research infrastructure. Stat Med 2010;29:1963-76.
8. Sox HC. Comparative effectiveness research: a progress report. Ann Intern Med 2010;153:469-72.
9. Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, et al. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med 2009;151:206-9.
10. Ruperto N, Ravelli A, Murray K, Lovell DJ, Andersson-Gare B, Feldman BM, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003;42:1452-9. (Pubitemid 37508918)
11. Miller FM, Rider LG, Chung Y, Cooper R, Danko K, Farewell V, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathy. Rheumatology (Oxford) 2001;40:1262-73.
12. Ruperto N, Pistorio A, Ravelli A, Rider LG, Pilkington C, Oliveira S, et al. The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis. Arthritis Care Res (Hoboken) 2010;62:1533-41.
13. Rider LG, Giannini EH, Brunner HI, Ruperto N, James-Newton L, Reed AM, et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004;50:2281-90. (Pubitemid 38924407)
14. Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D, Pilkington C, et al. Defining clinical improvement in adult and juvenile myositis. J Rheumatol 2003;30:603-17. (Pubitemid 36301957)